Castle Creek Arbitrage’s Cerevel Therapeutics Holdings, Inc. Warrant CEREW Stock Holding History

Castle Creek Arbitrage’s Portfolio CEREW Stock Details CEREW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-49,052	Closed	-$699K	–	741
2021 Q2	$699K	Hold	49,052	–	–	0.04%	340
2021 Q1	$213K	Hold	49,052	–	–	0.01%	404
2020 Q4	$277K	Buy	+49,052	New	+$198K	0.02%	227

Castle Creek Arbitrage's CEREW Position: Q3 2021 in Review

Castle Creek Arbitrage sold out of Cerevel Therapeutics Holdings, Inc. Warrant (CEREW) in Q3 2021, closing a stake of 49,052 shares — an estimated $699K sold.

Castle Creek Arbitrage first reported a position in CEREW in Q4 2020 and held it in 3 quarters. The position peaked at $699K in Q2 2021. 0 funds tracked by Wall St. Rank hold CEREW as of Q3 2021.

Castle Creek Arbitrage reported no remaining Cerevel Therapeutics Holdings, Inc. Warrant position as of Q3 2021 after selling out during the quarter.
Castle Creek Arbitrage sold 49,052 Cerevel Therapeutics Holdings, Inc. Warrant shares in Q3 2021, an estimated $699K.
Castle Creek Arbitrage first reported a position in Cerevel Therapeutics Holdings, Inc. Warrant in Q4 2020 and held it in 3 quarters.
Castle Creek Arbitrage's Cerevel Therapeutics Holdings, Inc. Warrant position peaked at $699K in Q2 2021.
0 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Warrant as of Q3 2021.

Based on Castle Creek Arbitrage's 13F filing for Q3 2021, filed 15 Nov 2021.